FINDEX Inc. (JP:3649)
:3649
3649 Stock Chart & Stats
¥824.00
-¥8.00(-0.93%)
At close: 4:00 PM EST
¥824.00
-¥8.00(-0.93%)
Day’s Range― - ―
52-Week Range¥636.00 - ¥1,011.00
Previous CloseN/A
Volume39.10K
Average Volume (3M)66.40K
Market Cap
¥21.85B
Enterprise Value¥18.87B
Total Cash (Recent Filing)¥2.38B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)18.1
Beta0.66
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.75%
Share Statistics
EPS (TTM)16.35
Shares Outstanding26,608,800
10 Day Avg. Volume40,110
30 Day Avg. Volume66,396
Financial Highlights & Ratios
PEG Ratio1.72
Price to Book (P/B)4.19
Price to Sales (P/S)3.73
P/FCF Ratio14.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)56.7
Revenue Forecast (FY)¥7.00B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetFINDEX's near-zero debt and high equity base materially reduce financial risk and interest burden, giving the company durable flexibility to fund operations, buybacks, or M&A without leverage strain. This conservatism supports resilience through economic cycles and preserves strategic optionality.
High & Improving MarginsSustained margin expansion to high operating and net margins indicates strong unit economics and operating leverage in FINDEX's software/services mix. High ROE reflects efficient capital use; durable margins enhance cash conversion and ability to reinvest or return capital while maintaining profitability through modest top-line cycles.
Product Penetration & Customer BaseIncremental user gains across hospitals, clinics and governments point to recurring revenue durability and deepening market penetration in healthcare/public IT. A diversified client footprint and sticky software deployments support predictable renewals, cross-sell potential and long-term cash flow visibility for organic growth.
Bears Say
Inconsistent Revenue GrowthHistoric variability in topline growth shows demand sensitivity in parts of FINDEX's end markets. While profitability is strong, inconsistent revenue undermines longer-term growth visibility, complicating capacity planning and the predictability of scale-driven margin gains across multiple-year planning horizons.
Operating Cash-flow VolatilityYear-to-year swings in operating cash flow, despite FCF near net income, indicate variability in working capital or timing of collections. Such volatility can stress near-term liquidity planning, constrain discretionary investment in product development, and make consistent funding of buybacks or higher dividends less certain.
Higher Payout Policy RiskShifting to a materially higher payout ratio and formal dividend floor increases cash returned to shareholders but reduces retained earnings available for organic investment or opportunistic M&A. Over a multi-year horizon this policy may tighten reinvestment capacity and limit funding flexibility despite a strong balance sheet.
FINDEX Inc. News
3649 FAQ
What was FINDEX Inc.’s price range in the past 12 months?
FINDEX Inc. lowest stock price was ¥636.00 and its highest was ¥1011.00 in the past 12 months.
What is FINDEX Inc.’s market cap?
FINDEX Inc.’s market cap is ¥21.85B.
When is FINDEX Inc.’s upcoming earnings report date?
FINDEX Inc.’s upcoming earnings report date is May 20, 2026 which is in 41 days.
How were FINDEX Inc.’s earnings last quarter?
FINDEX Inc. released its earnings results on Feb 12, 2026. The company reported ¥16.35 earnings per share for the quarter, beating the consensus estimate of N/A by ¥16.35.
Is FINDEX Inc. overvalued?
According to Wall Street analysts FINDEX Inc.’s price is currently Overvalued.
Does FINDEX Inc. pay dividends?
FINDEX Inc. pays a Semiannually dividend of ¥9 which represents an annual dividend yield of 1.75%. See more information on FINDEX Inc. dividends here
What is FINDEX Inc.’s EPS estimate?
FINDEX Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FINDEX Inc. have?
FINDEX Inc. has 26,608,800 shares outstanding.
What happened to FINDEX Inc.’s price movement after its last earnings report?
FINDEX Inc. reported an EPS of ¥16.35 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.432%.
Which hedge fund is a major shareholder of FINDEX Inc.?
Currently, no hedge funds are holding shares in JP:3649
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
FINDEX Inc.
FINDEX Inc. (3649) is a leading Japanese company specializing in the development and provision of medical information systems. The company focuses on creating software solutions that enhance healthcare operations, including electronic medical records (EMR), medical imaging systems, and other healthcare IT infrastructure. FINDEX Inc. aims to improve efficiency and accuracy within medical facilities by integrating advanced technology with healthcare services.
Technical Analysis
Options Prices
Currently, No data available
---